Undervalued Stocks Based On Cash Flows

Results

806

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

806 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
SPT
US$9.55-5.0%-36.2%US$599.3mUS$10.441.2107.1%n/aSoftware
KAMART
฿6.95-4.1%-9.7%฿8.8b฿12.0013.525.5%6.3%Household
AZN
UK£115.60-3.6%-1.5%UK£179.3bUK£156.7023.213.7%2.0%Pharmaceuticals & Biotech
R3NK
€51.161.9%-17.7%€5.2b€65.3551.628.4%1.1%Capital Goods
MUR
zł38.70-0.1%-2.0%zł1.6bzł50.778.412.4%12.7%Real Estate Management and Development
NEWA B
SEK 91.90-1.7%-10.8%SEK 12.2bSEK 114.2515.920.6%3.3%Consumer Durables
FDV
AU$0.320%-8.6%AU$139.4mAU$0.512.587.3%n/aMedia
TIMA
€43.701.2%-5.6%€922.1m€75.0020.916.0%3.2%Consumer Services
COA
UK£0.83-2.7%11.7%UK£1.6bUK£1.2118.816.9%2.9%Consumer Durables
NCH2
€7.85-1.3%-14.0%€982.1m€10.521.8106.7%n/aCapital Goods
MSAB B
SEK 89.200.7%52.2%SEK 1.6bSEK 96.0023.520.3%1.8%Software
688390
CN¥69.481.9%43.4%CN¥16.9bCN¥124.4763.145.3%0%Capital Goods
ALIG
SEK 125.20-1.4%-21.2%SEK 13.3bSEK 151.3324.122.2%2.6%Capital Goods
DXRX
UK£1.45-4.6%5.5%UK£123.1mUK£2.131268.887.0%n/aPharmaceuticals & Biotech
2310
ر.س13.341.0%-28.9%ر.س9.7bر.س16.541.9100.8%7.5%Materials
ENTERO
₹1,408.20-1.3%10.4%₹61.0b₹1,614.0048.934.2%n/aHealthcare
CSU
CA$2,990.99-9.5%-31.9%CA$65.5bCA$3,959.7847.514.9%0.2%Software
HBT
US$36.942.8%47.1%US$1.4bUS$40.401.828.5%2.7%Banks
6526
JP¥2,026.503.0%-32.8%JP¥373.8bJP¥2,400.0046.233.2%2.5%Semiconductors
3180
JP¥1,564.007.3%-11.2%JP¥19.5bJP¥1,900.0021.522.3%1.2%Consumer Services
BONEX
SEK 223.601.0%-21.1%SEK 14.7bSEK 356.5868.832.2%n/aPharmaceuticals & Biotech
6590
JP¥4,415.003.0%129.2%JP¥300.6bJP¥5,666.6728.332.5%1.4%Semiconductors
LHV1T
€3.35-0.1%-6.3%€1.1b€4.401.521.1%5.1%Banks
GLOO
US$3.20-8.0%n/aUS$285.7mUS$12.332.1105.5%n/aSoftware
Page 1 of 23
Undervalued Stocks Based On Cash Flows - Investing Ideas - Simply Wall St